Association between long-term acitretin therapy and osteoporosis: No evidence of increased risk

Clinical and Experimental Dermatology

Volumn 28, Issue 3, 2003, Pages 307-309

  McMullen, E A ^a   McCarron, P ^b   Irvine, D ^a   Dolan, O M ^a   Allen, G E ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE; RETINOID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CAUCASIAN; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LONG TERM CARE; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RETINOL INTOXICATION; RISK FACTOR; SKIN DISEASE;

ACITRETIN; ADULT; AGED; BONE DENSITY; CHRONIC DISEASE; DENSITOMETRY, X-RAY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR NECK; HUMANS; KERATOLYTIC AGENTS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK ASSESSMENT; SKIN DISEASES;

EID: 0038115479     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01265.x     Document Type: Article

References (10)

1. Wolbach SB. Vitamin-A deficiency and excess in relation to skeletal growth. J Bone Joint Surg 1957; 29: 171-92.
2. Bartolozzi G, Bernini G. Chronic hypervitaminosis A. Helv Paediatr Acta 1970; 25: 301-4.
3. DiGiovanna JJ, Sollitto RB, Donita L et al. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995; 131: 1263-7.
4. Okada N, Nomura M, Morimoto S et al. Bone mineral density of the lumbar spine in psoriatic patients with long-term etretinate therapy. Dermatol 1995; 21: 308-11.
5. World Health Organization Study Group. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva: WHO, 1994.
6. Stata Statistical Software release 7.0. College Station: Stata Corporation, 2000.
7. DiGiovanna JJ, Peck GL. Retinoid toxicity. Prog Dermatolol 1987; 21: 1-7.
8. DiGiovanna JJ, Helfgott R, Gerber LH, Peck GL. Extraspinal tendon and ligament calcification associated with longterm therapy with etretinate. N Engl J Med 1986: 315: 1177-82.
9. Larsen FG, lacobsen P, Larsen CG et al. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients. Pharmacol Toxicol 1988; 62: 159-65.
10. Brindley C. An overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670 etretin). Dermatologica 1989; 178: 179-87.